Oxford, United Kingdom

Charles David Ogilvy Potter


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles David Ogilvy Potter: Innovator in Needleless Syringe Technology

Introduction

Charles David Ogilvy Potter is a notable inventor based in Oxford, GB. He is recognized for his innovative contributions to medical technology, particularly in the field of drug delivery systems. His work has the potential to revolutionize how therapeutic agents are administered, making treatments more efficient and less invasive.

Latest Patents

Potter holds a patent for a needleless syringe particle delivery system. This system features an elongate nozzle connected to a sealed chamber that contains gas at super-atmospheric pressure along with therapeutic particles. Upon the release of gas from the chamber, a flow is created that entrains the particles, allowing them to pass through the nozzle at supersonic speed for delivery to a target surface. This innovative approach eliminates the need for needles, enhancing patient comfort and safety.

Career Highlights

Throughout his career, Potter has made significant strides in the field of medical technology. His work at Powderject Research Limited has positioned him as a leader in the development of advanced drug delivery systems. With a focus on improving patient outcomes, he continues to push the boundaries of what is possible in medical innovation.

Collaborations

Potter has collaborated with esteemed colleagues such as Brian John Bellhouse and Paul Rudd Drayson. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Charles David Ogilvy Potter's contributions to the field of needleless syringe technology exemplify the spirit of innovation. His patented systems not only enhance the delivery of therapeutic agents but also pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…